Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maillet, J.-M.
Right arrow Articles by Brodaty, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maillet, J.-M.
Right arrow Articles by Brodaty, D.
(Chest. 2003;123:1361-1366.)
© 2003 American College of Chest Physicians

Frequency, Risk Factors, and Outcome of Hyperlactatemia After Cardiac Surgery*

Jean-Michel Maillet, MD; Paul Le Besnerais, MD; Manuel Cantoni, MD; Patrick Nataf, MD; Alain Ruffenach, MD; Arrigo Lessana, MD and Denis Brodaty, MD

* From the Cardiovascular and Thoracic Surgery Intensive Care Unit (Drs. Maillet and Brodaty), and Departments of Cardiology (Dr. Le Besnerais), Anesthesiology (Dr. Cantoni), and Cardiac Surgery (Drs. Nataf, Ruffenach, and Lessana), Centre Cardiologique du Nord, Saint-Denis, France.

Correspondence to: Jean-Michel Maillet, MD, Centre Cardiologique du Nord, 32 à 36 rue des Moulins Gémeaux, Saint-Denis Cedex 93207, France

Study objective: To determine the respective frequencies, risk factors, and outcomes of no hyperlactatemia (NHL), immediate hyperlactatemia (IHL), or late hyperlactatemia (LHL) > 3 mmol/L after cardiac surgery.

Design: Prospective and observational study.

Setting: Cardiac surgery ICU in a 130-bed private community nonteaching hospital.

Patients: Consecutive patients (n = 325) undergoing cardiopulmonary bypass (CPB) for cardiac surgery.

Intervention: None.

Measurements: Arterial blood gas levels and lactate concentrations were measured at ICU admission, 4 h after surgery, between 6 h and 16 h after surgery, and on day 1.

Main results: Sixty-seven patients (20.6%) had an IHL on ICU admission, and 56 patients (17.2%) acquired LHL during their ICU stay. ICU mortality was 1.5% for NHL, 3.6% for LHL, and 14.9% for IHL groups (p < 0.0001). The three groups differed significantly for elective surgery, type of operation, CPB duration, intraoperative mean arterial pressure, and intraoperative and postoperative use of vasopressor. Independent risk factors for IHL were nonelective surgery, CPB duration, and intraoperative use of vasopressor. Logistic regression identified hyperglycemia and epinephrine therapy for LHL as postoperative risk factors. Receiver operating characteristic curves showed that IHL more accurately predicted ICU mortality than LHL.

Conclusions: Hyperlactatemia is common after cardiac surgery. A lactate threshold of 3 mmol/L at ICU admission is able to identify a population at risk of morbidity and mortality after cardiac surgery.

Key Words: cardiac surgery • lactate acidosis • outcome • risk factor




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
I. Kirkeby-Garstad, U. Wisloff, E. Skogvoll, T. Stolen, A.-E. Tjonna, R. Stenseth, and O. F. Sellevold
The marked reduction in mixed venous oxygen saturation during early mobilization after cardiac surgery: the effect of posture or exercise?
Anesth. Analg., June 1, 2006; 102(6): 1609 - 1616.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
G J Rodrigo and C Rodrigo
Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma
Emerg. Med. J., June 1, 2005; 22(6): 404 - 408.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. McKendry, H. McGloin, D. Saberi, L. Caudwell, A. R Brady, and M. Singer
Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery
BMJ, July 31, 2004; 329(7460): 258.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Krasemann and J.-M. Maillet
Infant Blood Transfusions
Chest, February 1, 2004; 125(2): 799 - 800.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.